Sofia Martins Sousa, Cristina Pinto Ribeiro Xavier, Maria Helena Vasconcelos, Andreia Palmeira (2023)
Repurposing some of the Well-known Non-steroid Anti-inflammatory
Drugs (NSAIDs) for Cancer Treatment.
Current Topics in Medicinal Chemistry23: 1171.
DOI: 10.2174/1568026623666230130150029
Kamil Szupryczyński, Przemysław Czeleń, Tomasz Jeliński, Beata Szefler (2024)
What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review.
International Journal of NanomedicineVolume 19: 9503.
DOI: 10.2147/IJN.S469217
Sagarika Saha, Sanket Bapat, Durairaj Vijayasarathi, Renu Vyas (2025)
Exploring potential biomarkers and lead molecules in gastric cancer by network biology, drug repurposing and virtual screening strategies.
Molecular Diversity29: 2341.
DOI: 10.1007/s11030-024-10995-6
Lixia Fu, Ruifen Xue, Jie Chen, Guoshu Jia, Xiaocong Pang, Yimin Cui (2025)
Comparative Assessment of Pivotal Trials Supporting the Indication Approvals of Innovative and Modified New Anticancer Drugs in China, 2016–2022.
Health Data Science5: .
DOI: 10.34133/hds.0263
Lixia Fu, Songtao Dong, Ran Xie, Guoshu Jia, Nan Zhao, Qian Xiang, Xiwei Ji, Xia Zhao, Xiaoyuan Chen, Lingyue Ma, Yimin Cui (2025)
A multi-dimensional comparative study of 505(b)(2) NDAs approved by FDA and Class 2 NDAs approved by NMPA from 2017 to 2023: Uncovering trends, characteristics, and regulation of modified new drugs.
Regulatory Toxicology and Pharmacology
: 105864.
DOI: 10.1016/j.yrtph.2025.105864
Walther Bild, Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela-Carmen Ababei, Aurelian Bogdan Stana, Gabriela Dumitrița Stanciu, Bogdan Savu, Veronica Bild (2022)
Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases.
Biomolecules12: 1429.
DOI: 10.3390/biom12101429
Ricardo P. Garay (2023)
Recent clinical trials with stem cells to slow or reverse normal aging processes.
Frontiers in Aging4: .
DOI: 10.3389/fragi.2023.1148926
Roohi Mohi-ud-din, Apporva Chawla, Pooja Sharma, Prince Ahad Mir, Faheem Hyder Potoo, Željko Reiner, Ivan Reiner, Dilek Arslan Ateşşahin, Javad Sharifi-Rad, Reyaz Hassan Mir, Daniela Calina (2023)
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
European Journal of Medical Research28: .
DOI: 10.1186/s40001-023-01275-4
Katarzyna Ochenkowska, Aveeva Herold, Éric Samarut (2022)
Zebrafish Is a Powerful Tool for Precision Medicine Approaches to Neurological Disorders.
Frontiers in Molecular Neuroscience15: .
DOI: 10.3389/fnmol.2022.944693
Omolbanin Amjadi, Akbar Hedayatizadeh-Omran, Ehsan Zaboli, Ghasem Janbabaei, Sergio A Lira, Ghasem Ahangari (2025)
Revealing New Prospects: Antipsychotic Drugs Induces Anti-tumor Effects against Gastric Cancer through Inducing Apoptosis.
Current Cancer Drug Targets25: 496.
DOI: 10.2174/0115680096303479240614061136
Andrew Ivsins, Jeanette M. Bowles, Manal Mansoor, Thomas Kerr, Geoff Bardwell (2024)
Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs.
International Journal of Drug Policy133: 104601.
DOI: 10.1016/j.drugpo.2024.104601
Vrushali Neve, Abhijeet Kamble, Pawan Karwa (2024)
Repurposing of Drug Aspirin in Colon Cancer: Therapeutic Approach.
Clinical Cancer Investigation Journal13: 23.
DOI: 10.51847/brEvhxSqb9